Medicare Enrolled
Dr. Padmini Tummala, MD
Cardiovascular Disease · Upland, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tummala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tummala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tummala
Dr. Padmini Tummala is a cardiovascular disease specialist in Upland, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tummala performed 1,593 Medicare services across 1,101 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tummala received a total of $7,070 from 29 pharmaceutical and/or device companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tummala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 1,593 Medicare services
$7,070 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,593
Medicare services
Bottom 45% in CA for cardiovascular disease
1,101
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
501 | $97 | $273 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
138 | $11 | $36 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
131 | $46 | $122 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
119 | $7 | $18 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
116 | $48 | $110 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
107 | $156 | $522 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $130 | $360 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
61 | $97 | $249 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
60 | $76 | $225 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
40 | $2 | $9 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
39 | $6 | $14 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
38 | $55 | $212 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
38 | $20 | $54 |
| Heart muscle strain imaging | 36 | $9 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $141 | $365 |
| 3D radiographic procedure A radiographic imaging technique that creates three-dimensional representations of internal structures. |
25 | $8 | $36 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
18 | $373 | $1,200 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
15 | $21 | $231 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
13 | $714 | $1,934 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.2% high complexity
21.7% medium
69.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,070
Total received (2018-2024)
Avg $1,010/year across 7 years
Top 34% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
391
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,058 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,220
2023
$1,223
2022
$1,025
2021
$1,121
2020
$983
2019
$628
2018
$870
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$197
SCPHARMACEUTICALS INC.
$168
Novartis Pharmaceuticals Corporation
$143
Merck Sharp & Dohme LLC
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
Kiniksa Pharmaceuticals International, plc
$84
Janssen Pharmaceuticals, Inc
$79
Esperion Therapeutics, Inc.
$58
E.R. Squibb & Sons, L.L.C.
$56
PFIZER INC.
$53
SANOFI-AVENTIS U.S. LLC
$37
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$33
Abbott Laboratories
$21
Edwards Lifesciences Corporation
$21
Boston Scientific Corporation
$19
Top 3 companies account for 41.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,165
Amgen Inc.
$836
Janssen Pharmaceuticals, Inc
$766
AstraZeneca Pharmaceuticals LP
$709
SCPHARMACEUTICALS INC.
$592
Merck Sharp & Dohme LLC
$454
Boehringer Ingelheim Pharmaceuticals, Inc.
$406
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$343
Esperion Therapeutics, Inc.
$257
Amarin Pharma Inc.
$195
Alnylam Pharmaceuticals Inc.
$162
PFIZER INC.
$162
Abbott Laboratories
$154
SANOFI-AVENTIS U.S. LLC
$140
E.R. Squibb & Sons, L.L.C.
$118
ARALEZ PHARMACEUTICALS US INC.
$105
Kiniksa Pharmaceuticals International, plc
$84
Kowa Pharmaceuticals America, Inc.
$80
Kiniksa Pharmaceuticals, Ltd.
$62
HeartFlow, Inc.
$52
Merck Sharp & Dohme Corporation
$50
Boston Scientific Corporation
$45
Lexicon Pharmaceuticals, Inc.
$35
PORTOLA PHARMACEUTICALS, INC.
$23
Edwards Lifesciences Corporation
$21
Xeris Pharmaceuticals, Inc.
$17
Regeneron Healthcare Solutions, Inc.
$12
Gilead Sciences, Inc.
$11
Allergan Inc.
$11
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · Arcalyst · BRILINTA · BYSTOLIC · CAMZYOS · COROFLOW · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · FARXIGA · FUROSCIX · Inpefa · JARDIANCE · KEVEYIS · LEQVIO · LOKELMA · LifeVest · Livalo · MULTAQ · Mitra Clip system · NEXLETOL · ONPATTRO · PRADAXA · PRALUENT ALIROCUMAB INJECTION · Repatha · VERQUVO · VYNDAQEL · Vascepa · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
177
Per 100K population
8.1
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tummala is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tummala experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tummala performed 501 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tummala receive payments from pharmaceutical companies?
Yes. Dr. Tummala received a total of $7,070 from 29 companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tummala's costs compare to other cardiologists in Upland?
Dr. Tummala's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tummala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Upland
Browse cardiologists in Upland ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology